Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.
Red Flag Alert: Only 5 S&P 500 Index ($SPX) stocks had a 100% Barchart Opinion on Friday, April 4, and all experienced a down day, signaling market distress. Market Conditions: S&P 500 and Nasdaq-100 Index...
Drug stocks like Cencora tend to be recession-proof, making today’s Chart of the Day especially relevant following a tariffs-driven selloff.
3 Reasons COR Has Explosive Upside Potential
Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4
GE HealthCare Technologies Inc. GEHC, yesterday, announced the completion of its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (“NMP”) from Sumitomo Chemical, giving it full...
The S&P 500 wrapped up the worst quarter since the third quarter of 2022, plunging 4.6%, due to escalating trade tensions and concerns over stagflation.The Trump administration imposed tariffs on Canada,...
DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM). The...
Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)
DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With an...